Regeneron confirms FDA won’t approve myeloma drug over manufacturing issues
Bio Pharma Dive
AUGUST 21, 2024
Company executives had previously warned investors that a delay was likely due to issues at a facility run by third-party manufacturer.
Bio Pharma Dive
AUGUST 21, 2024
Company executives had previously warned investors that a delay was likely due to issues at a facility run by third-party manufacturer.
Pharmaceutical Technology
SEPTEMBER 25, 2024
Discover the leading Biotechnology Equipment Manufacturers, Companies and Suppliers. Download the free Buyer's Guide today for full details.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 18, 2024
Called Advanced Medicine Partners, the new company will offer specialized cell and gene therapy manufacturing services to biotech and pharma clients.
Pharmaceutical Technology
JULY 16, 2024
As the EU anticipates GLP-1RA shortages throughout 2024, Corden Pharma has pledged $980m to increase manufacturing capacity.
Advertisement
A dedicated Case Manager provides end-to-end supply chain management and 24/7 oversight and support to help ensure the seamless manufacturing and distribution of each therapy dose to every patient.
Bio Pharma Dive
JUNE 28, 2024
The complete response letter follows other recent manufacturing-related rejections, including one for a cell therapy from Abeona Therapeutics.
Pharmaceutical Technology
SEPTEMBER 13, 2024
Lilly has announced a significant expansion of its manufacturing presence in Ireland, with a $1bn investment earmarked for its Limerick site.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial.
Let's personalize your content